{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T11:31:33Z","timestamp":1784287893386,"version":"3.55.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007298","name":"Urmia University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007298","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tissue and Cell"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.tice.2024.102359","type":"journal-article","created":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T02:50:48Z","timestamp":1710298248000},"page":"102359","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Benefits of conditioned medium of nicotine-pulsed mesenchymal stem cells in experimental autoimmune hepatitis"],"prefix":"10.1016","volume":"88","author":[{"given":"Leila","family":"Mahmoudzadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyyed Meysam","family":"Abtahi Froushani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahim","family":"Hobbenaghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Mahmoudian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vahid","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tice.2024.102359_bib1","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.lfs.2018.03.009","article-title":"Nicotine and caffeine alter the effects of the LPS- primed mesenchymal stem cells on the co-cultured neutrophils","volume":"199","author":"Abbasi","year":"2018","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.tice.2024.102359_bib2","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/hep.510310136","article-title":"Grading and staging the histopathological lesions of chronic hepatitis: the Knodell histology activity index and beyond","volume":"31","author":"Brunt","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.tice.2024.102359_bib3","first-page":"11","article-title":"Characterization of the immunomodulatory properties of alveolar bone-derived mesenchymal stem cells","author":"Cao","year":"2020","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.tice.2024.102359_bib4","doi-asserted-by":"crossref","DOI":"10.4103\/2225-4110.126172","article-title":"Effect of oxidative phytochemicals on nicotine-stressed UMNSAH\/DF-1 cell line","volume":"4","author":"Chakraborty","year":"2014","journal-title":"J. Tradit. Complement. Med."},{"key":"10.1016\/j.tice.2024.102359_bib5","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.imlet.2014.10.021","article-title":"Mesenchymal stem cells ameliorate experimental autoimmune hepatitis by activation of the programmed death 1 pathway","volume":"162","author":"Chen","year":"2014","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.tice.2024.102359_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17122007","article-title":"Immunopathogenic mechanisms of autoimmune hepatitis: how much do we know from animal models?","author":"Christen","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tice.2024.102359_bib7","first-page":"1715","article-title":"Current and prospective pharmacotherapy for autoimmune hepatitis","volume":"15","author":"Czaja","year":"2014","journal-title":"Pharmacother"},{"key":"10.1016\/j.tice.2024.102359_bib8","article-title":"Pristimerin as a novel hepatoprotective agent against experimental autoimmune hepatitis","volume":"9","author":"El-Agamy","year":"2018","journal-title":"Front. Pharmacol. 37"},{"key":"10.1016\/j.tice.2024.102359_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.01881","article-title":"Quantitative Proteomic analysis reveals That arctigenin alleviates concanavalin a-induced hepatitis Through suppressing immune system and regulating autophagy","volume":"9","author":"Feng","year":"2018","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.tice.2024.102359_bib10","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/hep.23792","article-title":"A multifaceted imbalance of T cells with regulatory function characterizes type 1 autoimmune hepatitis","volume":"52","author":"Ferri","year":"2010","journal-title":"hepatology"},{"issue":"2","key":"10.1016\/j.tice.2024.102359_bib11","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.molmed.2011.10.004","article-title":"The immunomodulatory capacity of mesenchymal stem cells","volume":"18","author":"Gebler","year":"2012","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.tice.2024.102359_bib12","unstructured":"Ghaffary, E.M. and S.M.A. Froushani (2020). \"Immunomodulatory benefits of mesenchymal stem cells treated with Caffeine in adjuvant-induced arthritis.\" Life sciences."},{"key":"10.1016\/j.tice.2024.102359_bib13","doi-asserted-by":"crossref","unstructured":"Ghaneialvar, H., et al. (2017). \"Characterization and Classification of Mesenchymal Stem Cells in Several Species Using Surface Markers for Cell Therapy Purposes.\" Clin Biochem.","DOI":"10.1007\/s12291-017-0641-x"},{"issue":"6","key":"10.1016\/j.tice.2024.102359_bib14","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.4049\/jimmunol.1600228","article-title":"Autoimmune hepatitis inflammation mimicking human mouse liver triggers unremitting transient expression of transgenic IL-12 in","volume":"197","author":"Gil-Farina","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.tice.2024.102359_bib15","first-page":"295","article-title":"Apoptosis-induced lymphopenia in sepsis and other severe injuries","volume":"22","author":"Girardot","year":"2017","journal-title":"J. Appl. Physiol."},{"issue":"4","key":"10.1016\/j.tice.2024.102359_bib16","first-page":"385","article-title":"Chronopharmacokinetics of nicotine","volume":"60","author":"Gries","year":"1996","journal-title":"Pharmacokinet. Drug Dispos."},{"issue":"1","key":"10.1016\/j.tice.2024.102359_bib17","first-page":"7","article-title":"Current and novel immunosuppressive therapy for autoimmune hepatitis","volume":"35","author":"Heneghan, M","year":"2002","journal-title":"Perspect. Clin. Hepatol."},{"key":"10.1016\/j.tice.2024.102359_bib18","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/0023677215572841","article-title":"The concanavalin A model of acute hepatitis in mice","volume":"49","author":"Heymann","year":"2015","journal-title":"Lab. Anim."},{"key":"10.1016\/j.tice.2024.102359_bib19","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1440-1746.2010.06579.x","article-title":"Treatment of autoimmune hepatitis: a review of current and evolving therapies","volume":"26","author":"Jothimani","year":"2010","journal-title":"J. gastrology Hepatol."},{"issue":"11","key":"10.1016\/j.tice.2024.102359_bib20","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1002\/ps.4249","article-title":"Binding of imidacloprid, thiamethoxam and N-desmethylthiamethoxam to nicotinic receptors of Myzus persicae: pharmacological profiling using neonicotinoids, natural agonists and antagonists","volume":"72","author":"Kayser","year":"2016","journal-title":"Pest Manag. Sci."},{"issue":"13","key":"10.1016\/j.tice.2024.102359_bib21","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.3748\/wjg.v20.i13.3597","article-title":"Clinicopathological study of primary biliary cirrhosis with interface hepatitis compared to autoimmune hepatitis","volume":"20","author":"Kobayashi","year":"2014","journal-title":"World J. Gastrol."},{"issue":"4","key":"10.1016\/j.tice.2024.102359_bib22","article-title":"Altered immune responses in mice after receiving nicotine-pulsed mesenchymal stem cell-conditioned medium","volume":"12","author":"Mahmoudzadeh","year":"2021","journal-title":"Arch. Adv. Biosci."},{"key":"10.1016\/j.tice.2024.102359_bib23","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.advms.2016.07.006","article-title":"Nicotine can modulate the effects of the mesenchymal stem cells on neutrophils","volume":"62","author":"Pourtayeb","year":"2016","journal-title":"Adv. Med. Sci."},{"key":"10.1016\/j.tice.2024.102359_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2017.05.002","article-title":"Myeloperoxidase: a new player in autoimmunity","author":"Strzepa","year":"2017","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.tice.2024.102359_bib25","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/9437043","article-title":"Autoimmune hepatitis immunologically triggered liver pathogenesis diagnostic and therapeutic strategies","author":"Sucher","year":"2019","journal-title":"\" Immunol. Res."},{"key":"10.1016\/j.tice.2024.102359_bib26","unstructured":"Valdez-Miramontes, C.E., et al. (2020). \"Nicotine modulates molecules of the innate immune response in epithelial cells and macrophages during infection with M. tuberculosis.\""},{"issue":"21","key":"10.1016\/j.tice.2024.102359_bib27","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.3748\/wjg.14.3306","article-title":"Aetiopathogenesis of autoimmune hepatitis","volume":"14","author":"Vergani","year":"2008","journal-title":"World J. Gastroenterol."},{"issue":"4","key":"10.1016\/j.tice.2024.102359_bib28","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3109\/08916930903305641","article-title":"Interleukin-1 receptor antagonist (IL-1Ra) and IL-1Ra producing mesenchymal stem cells as modulators of diabetogenesis","volume":"43","author":"Volarevic","year":"2009","journal-title":"Autoimmunity"},{"key":"10.1016\/j.tice.2024.102359_bib29","doi-asserted-by":"crossref","first-page":"16","DOI":"10.7150\/ijms.21666","article-title":"Ethical and safety issues of stem cell-based therapy","volume":"15","author":"Volarevic","year":"2018","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.tice.2024.102359_bib30","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jhep.2012.11.010","article-title":"Infliximab as a rescue treatment in difficult-to-treat autoimmune hepatitis","volume":"58","author":"Weiler-Normann","year":"2012","journal-title":"J. Hepatol."}],"container-title":["Tissue and Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040816624000600?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040816624000600?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T12:22:46Z","timestamp":1718454166000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040816624000600"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":30,"alternative-id":["S0040816624000600"],"URL":"https:\/\/doi.org\/10.1016\/j.tice.2024.102359","relation":{},"ISSN":["0040-8166"],"issn-type":[{"value":"0040-8166","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Benefits of conditioned medium of nicotine-pulsed mesenchymal stem cells in experimental autoimmune hepatitis","name":"articletitle","label":"Article Title"},{"value":"Tissue and Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tice.2024.102359","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102359"}}